Cargando…

Ketamine for bipolar depression: an updated systematic review

BACKGROUND: The therapeutic potential of subanesthetic doses of ketamine appears promising in unipolar depression; however, its effectiveness in treating bipolar depression (BD) remains uncertain. OBJECTIVE: This systematic review aimed to summarize findings on the use of ketamine for the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fancy, Farhan, Haikazian, Sipan, Johnson, Danica E., Chen-Li, David C. J., Levinta, Anastasia, Husain, Muhammad I., Mansur, Rodrigo B., Rosenblat, Joshua D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	From Drug Misuse to Useful Drugs
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524067/ https://www.ncbi.nlm.nih.gov/pubmed/37771417 http://dx.doi.org/10.1177/20451253231202723

Ejemplares similares

Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study
por: Glue, Paul, et al.
Publicado: (2020)

The therapeutic potential of microdosing psychedelics in depression
por: Kuypers, Kim P.C.
Publicado: (2020)

Psychedelic treatment of functional neurological disorder: a systematic review
por: Butler, Matthew, et al.
Publicado: (2020)

Cannabidiol as a potential treatment for psychosis
por: Davies, Cathy, et al.
Publicado: (2019)

Improvement of functional neurological disorder after administration of esketamine nasal spray: a case report
por: Vendrell-Serres, Júlia, et al.
Publicado: (2021)

Will psilocybin lose its magic in the clinical setting?
por: Hayes, Caroline, et al.
Publicado: (2022)

Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine
por: O’Shaughnessy, David M., et al.
Publicado: (2021)

Classic psychedelics, health behavior, and physical health
por: Simonsson, Otto, et al.
Publicado: (2022)

The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics
por: Evens, Ricarda, et al.
Publicado: (2023)

History repeating: guidelines to address common problems in psychedelic science
por: van Elk, Michiel, et al.
Publicado: (2023)

Plasma BDNF concentrations and the antidepressant effects of six ketamine infusions in unipolar and bipolar depression
por: Zheng, Wei, et al.
Publicado: (2021)

Neurocognitive effects of six ketamine infusions and the association with antidepressant effects in treatment-resistant bipolar depression: a preliminary study
por: Zheng, Wei, et al.
Publicado: (2020)

Onychomycosis: An Updated Review
por: Leung, Alexander K.C., et al.
Publicado: (2020)

Lifecourse SEP and tobacco and cannabis use
por: Bowes, Lucy, et al.
Publicado: (2013)

Ketamine-induced affective switch in a patient with treatment-resistant depression
por: Banwari, Girish, et al.
Publicado: (2015)

Factors associated with changing alcohol consumption during the first UK lockdown
por: McAloney-Kocaman, Kareena, et al.
Publicado: (2022)

Alcohol use in adolescence as a risk factor for overdose in the 1986 Northern Finland Birth Cohort Study
por: Koivisto, Maarit K, et al.
Publicado: (2022)

Increasing prevalence of illicit drug use among employees at Swedish workplaces over a 25-year period
por: Feltmann, Kristin, et al.
Publicado: (2022)

Evidence of the emergence of illicit benzodiazepines from online drug forums
por: Sarker, Abeed, et al.
Publicado: (2022)

Parental alcohol and drug abuse and offspring mortality by age 10: a population-based register study
por: Berg, Venla, et al.
Publicado: (2022)

Disentangling the association between alcohol consumption and employment status: causation, selection or confounding?
por: Mangot-Sala, Lluís, et al.
Publicado: (2022)

Anti-VEGF drugs in the prevention of blindness
por: Yorston, David
Publicado: (2014)

Anti-VEGF treatment for acute ROP – not yet recommended!
por: Gilbert, Clare
Publicado: (2014)

The Situation of Chemokine Ligands and Receptors Gene Expression, Following the Oral Administration of Drug Mannuronic Acid in Rheumatoid Arthritis Patients
por: Aslani, Mona, et al.
Publicado: (2020)

Chitinases: Therapeutic Scaffolds for Allergy and Inflammation
por: Madan, Kirtika, et al.
Publicado: (2020)

Anti-Inflammatory and Gastroprotective Properties of Aspirin - Entrapped Solid Lipid Microparticles
por: Chime, Salome A., et al.
Publicado: (2020)

Comparative efficacy of generic nifedipine versus brand‐name amlodipine for hypertension management in Taiwan
por: Lee, Hao‐Wei, et al.
Publicado: (2022)

Sodium Valproate induced priapism in an adult with bipolar affective disorder
por: Bansal, Shwetank, et al.
Publicado: (2013)

Update in Cardiac Pacing
por: Verma, Nishant, et al.
Publicado: (2019)

Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action
por: Irwin, Madison N., et al.
Publicado: (2021)

An open-label study to estimate the effect of steady-state erythromycin on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban in subjects with renal impairment and normal renal function
por: Moore, Kenneth T, et al.
Publicado: (2014)

Hydroxychloroquine in Dermatology and Beyond: Recent Update
por: Sardana, Kabir, et al.
Publicado: (2020)

Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder
por: Gupta, Sumit Kumar, et al.
Publicado: (2014)

Esketamine hydrochloride for treatment-resistant depression
Publicado: (2021)

Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice
por: Guarracino, Fabio, et al.
Publicado: (2018)

Risperidone-induced respiratory depression in a neonate through breast milk
por: Pasi, Rachna, et al.
Publicado: (2023)

Effects of boceprevir and telaprevir on the pharmacokinetics of dolutegravir
por: Johnson, Mark, et al.
Publicado: (2014)

Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth
por: Chisamore, Noah, et al.
Publicado: (2023)

Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
por: Rong, Carola, et al.
Publicado: (2018)

MYOCRISIN
Publicado: (1941)

Cannot write session to /tmp/vufind_sessions/sess_1de6cltsbngi0qsrk989gp620t